Vascular toxicity of ultra-small TiO2 nanoparticles and single walled carbon nanotubes in vitro and in vivo

Biomaterials

Volumn 63, Issue , 2015, Pages 1-13

  Bayat, Narges ^a   Lopes, Viviana R ^b   Schölermann, Julia ^c   Jensen, Lasse Dahl ^b   Cristobal, Susana ^a,b,d  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

^c UNIVERSITY OF BERGEN   (Norway)

^d UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Angiogenesis; Endothelium; Genotoxicity; Ultra small nanoparticles; Zebrafish

Indexed keywords

ENDOTHELIAL CELLS; NANOPARTICLES; NANOTUBES; NITRIC OXIDE; OXIDE MINERALS; PHYSICOCHEMICAL PROPERTIES; THERANOSTICS; TIO2 NANOPARTICLES; TITANIUM DIOXIDE; TOXICITY;

ANGIOGENESIS; ENDOTHELIUM; GENOTOXICITIES; ULTRA-SMALL; ZEBRAFISH;

SINGLE-WALLED CARBON NANOTUBES (SWCN);

LACTATE DEHYDROGENASE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SINGLE WALLED NANOTUBE; SUPEROXIDE; TITANIUM DIOXIDE NANOPARTICLE; WATER; CARBON NANOTUBE; MUTAGENIC AGENT; NANOPARTICLE; TITANIUM; TITANIUM DIOXIDE;

ACIDIFICATION; ANGIOGENESIS; ANIMAL EXPERIMENT; ANTIANGIOGENIC ACTIVITY; ARTICLE; CARDIOVASCULAR MORTALITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; DERMAL MICROVASCULAR ENDOTHELIAL CELL; DNA DAMAGE; EMBRYO; EMBRYO DEVELOPMENT; EMBRYOTOXICITY; EXPOSURE; GENE EXPRESSION; GENOTOXICITY; HEART EDEMA; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NANOTOXICOLOGY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; UPREGULATION; ZEBRA FISH; ANIMAL; ANIMAL EMBRYO; CELL LINE; CHEMISTRY; CONGENITAL MALFORMATION; CYTOLOGY; DRUG EFFECTS; EMBRYOLOGY; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; METABOLISM; PATHOLOGY; ULTRASTRUCTURE; VASCULARIZATION;

ANIMALS; CELL LINE; EMBRYO, NONMAMMALIAN; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MUTAGENS; NANOPARTICLES; NANOTUBES, CARBON; NEOVASCULARIZATION, PHYSIOLOGIC; REACTIVE OXYGEN SPECIES; SUPEROXIDES; TITANIUM; ZEBRAFISH;

EID: 84952664451     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.05.044     Document Type: Article

References (66)

1. Kim B.H., Lee N., Kim H., An K., Park Y.I., Choi Y., et al. Large-scale synthesis of uniform and extremely small-sized iron oxide nanoparticles for high-resolution T1 magnetic resonance imaging contrast agents. J. Am. Chem. Soc. 2011, 133:12624-12631.
2. Zheng J., Zhang C., Dickson R.M. Highly fluorescent, water-soluble, size-tunable gold quantum dots. Phys. Rev. Lett. 2004, 93:077402.
3. Corrigan J.F., Fuhr O., Fenske D. Metal chalcogenide clusters on the border between molecules and materials. Adv. Mater. 2009, 21:1867-1871.
4. Kim C.K., Kim T., Choi I.-Y., Soh M., Kim D., Kim Y.-J., et al. Ceria nanoparticles that can protect against ischemic stroke. Angew. Chem. Int. Ed. 2012, 51:11039-11043.
5. Soo Choi H., Liu W., Misra P., Tanaka E., Zimmer J.P., Itty Ipe B., et al. Renal clearance of quantum dots. Nat. Biotech. 2007, 25:1165-1170.
6. Kim B.H., Hackett M.J., Park J., Hyeon T. Synthesis, characterization, and application of ultrasmall nanoparticles. Chem. Mater. 2013, 26:59-71.
7. Huang K., Ma H., Liu J., Huo S., Kumar A., Wei T., et al. Size-dependent localization and penetration of ultrasmall gold nanoparticles in cancer cells, multicellular spheroids, and tumors in vivo. ACS Nano 2012, 6:4483-4493.
8. 2 nanoparticles disrupt microtubular networks in Arabidopsis thaliana. Plant Cell Environ. 2011, 34:811-820.
9. 2 production As a basis for exposure assessment. Environ. Sci. Technol. 2009, 43:4227-4233.
10. Meng J., Song L., Xu H., Kong H., Wang C., Guo X., et al. Effects of single-walled carbon nanotubes on the functions of plasma proteins and potentials in vascular prostheses. Nanomed. Nanotechnol. Biol. Med. 2005, 1:136-142.
11. Bianco A., Kostarelos K., Partidos C.D., Prato M. Biomedical applications of functionalised carbon nanotubes. Chem. Commun. 2005, 571-577.
12. Liu Z., Davis C., Cai W., He L., Chen X., Dai H. Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy. Proc. Natl. Acad. Sci. 2008, 105:1410-1415.
13. Singh R., Pantarotto D., Lacerda L., Pastorin G., Klumpp C., Prato M., et al. Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:3357-3362.
14. Lacerda L., Bianco A., Prato M., Kostarelos K. Carbon nanotubes as nanomedicines: from toxicology to pharmacology. Adv. Drug Deliv. Rev. 2006, 58:1460-1470.
15. Kam N., Wong S., O'Connell M., Wisdom J.A., Dai H. Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:11600-11605.
16. Yehia H.N., Draper R.K., Mikoryak C., Walker E.K., Bajaj P., Musselman I.H., et al. Single-walled carbon nanotube interactions with HeLa cells. J. Nanobiotechnol. 2007, 5:8.
17. Donaldson K., Stone V., Tran L.C., Kreyling W., Borm P.A. Nanotoxicology. Occup. Environ. Med. 2004, 61:727-728.
18. Staton C.A., Reed M.W.R., Brown N.J. A critical analysis of current in vitro and in vivo angiogenesis assays. Int. J. Exp. Pathol. 2009, 90:195-221.
19. Chan J., Bayliss P.E., Wood J.M., Roberts T.M. Dissection of angiogenic signaling in zebrafish using a chemical genetic approach. Cancer Cell 2002, 1:257-267.
20. Isogai S., Horiguchi M., Weinstein B.M. The vascular anatomy of the developing zebrafish: an atlas of embryonic and early larval development. Dev. Biol. 2001, 230:278-301.
21. Isogai S., Lawson N.D., Torrealday S., Horiguchi M., Weinstein B.M. Angiogenic network formation in the developing vertebrate trunk. Development 2003, 130:5281-5290.
22. Karlsson H. The comet assay in nanotoxicology research. Anal. Bioanal. Chem. 2010, 398:651-666.
23. Foucaud L.W., Wilson M.R., Brown D.M., Stone V. Measurement of reactive species production by nanoparticles prepared in biologically relevant media. Toxicol. Lett. 2007, 174:1-9.
24. Jensen Lasse D., Cao Z., Nakamura M., Yang Y., Bräutigam L., Andersson P., et al. Opposing effects of circadian clock genes bmal1 and period2 in regulation of VEGF-dependent angiogenesis in developing zebrafish. Cell Reports 2012, 2:231-241.
25. Arif E., Kumari B., Wagner M.C., Zhou W., Holzman L.B., Nihalani D. Myo1c is an unconventional myosin required for zebrafish glomerular development. Kidney Int. 2013, 84:1154-1165.
26. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (San Diego, Calif.) 2001, 25:402-408.
27. Shukla R.K., Sharma V., Pandey A.K., Singh S., Sultana S., Dhawan A. ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells. Toxicol. In Vitro 2011, 25:231-241.
28. Albini A., Mussi V., Parodi A., Ventura A., Principi E., Tegami S., et al. Interactions of single-wall carbon nanotubes with endothelial cells. Nanomed. Nanotechnol. Biol. Med. 2010, 6:277-288.
29. Alarifi S., Ali D., Verma A., Almajhdi F., Al-Qahtani A. Single-walled carbon nanotubes induce cytotoxicity and DNA damage via reactive oxygen species in human hepatocarcinoma cells. In Vitro CellDevBiol-Animal 2014, 1-9.
30. Auffan M., Rose J., Bottero J.-Y., Lowry G.V., Jolivet J.-P., Wiesner M.R. Towards a definition of inorganic nanoparticles from an environmental, health and safety perspective. Nat. Nano 2009, 4:634-641.
31. 2 nanoparticles in anatase and rutile crystal phase. Biol. Trace Elem. Res. 2011, 141:3-15.
32. Shang L., Nienhaus K., Nienhaus G. Engineered nanoparticles interacting with cells: size matters. J. Nanobiotechnol. 2014, 12:5.
33. Cho E.C., Zhang Q., Xia Y. The effect of sedimentation and diffusion on cellular uptake of gold nanoparticles. Nat. Nano 2011, 6:385-391.
34. Stark G. Functional consequences of oxidative membrane damage. J. Membr. Biol. 2005, 205:1-16.
35. Saquib Q., Al-Khedhairy A.A., Siddiqui M.A., Abou-Tarboush F.M., Azam A., Musarrat J. Titanium dioxide nanoparticles induced cytotoxicity, oxidative stress and DNA damage in human amnion epithelial (WISH) cells. Toxicol. In Vitro 2012, 26:351-361.
36. 2) nanoparticles at two trophic levels: plant and human lymphocytes. Chemosphere 2010, 81:1253-1262.
37. Kim J.S., Song K.S., Yu I.J. Evaluation of in vitro and in vivo genotoxicity of single-walled carbon nanotubes. Toxicol. Ind. Health 2013.
38. Naya M., Kobayashi N., Endoh S., Maru J., Honda K., Ema M., et al. In vivo genotoxicity study of single-wall carbon nanotubes using comet assay following intratracheal instillation in rats. Regul. Toxicol. Pharmacol. 2012, 64:124-129.
39. Potente M., Gerhardt H., Carmeliet P. Basic and therapeutic aspects of angiogenesis. Cell 2011, 146:873-887.
40. Jo D.H., Kim J.H., Son J.G., Song N.W., Kim Y.-I., Yu Y.S., et al. Anti-angiogenic effect of bare titanium dioxide nanoparticles on pathologic neovascularization without unbearable toxicity. Nanomed. Nanotechnol. Biol. Med. 2014, 10(5):1109-1117.
41. Bian K., Doursout M.-F., Murad F. Vascular system: role of nitric oxide in cardiovascular diseases. J. Clin. Hypertens. 2008, 10:304-310.
42. Verma S., Maitland A., Weisel R.D., Fedak P.W.M., Pomroy N.C., Li S.H., et al. Novel cardioprotective effects of tetrahydrobiopterin after anoxia and reoxygenation: Identifying cellular targets for pharmacologic manipulation. J. Thorac. Cardiovasc. Surg. 2002, 123:1074-1083.
43. 2 nanoparticles induce endothelial cell activation in a pneumocyte-endothelial co-culture model. Toxicol. In Vitro 2013, 27:774-781.
44. Staton C.A., Stribbling S.M., Tazzyman S., Hughes R., Brown N.J., Lewis C.E. Current methods for assaying angiogenesis in vitro and in vivo. Int. J. Exp. Pathol. 2004, 85:233-248.
45. Zimrin A.B., Villeponteau B., Maciag T. Models of in vitro angiogenesis: endothelial cell differentiation on fibrin but not matrigel is transcriptionally dependent. Biochem. Biophys. Res. Commun. 1995, 213:630-638.
46. Donovan D., Brown N.J., Bishop E.T., Lewis C.E. Comparison of three in vitro human 'angiogenesis' assays with capillaries formed in vivo. Angiogenesis 2001, 4:113-121.
47. Wang J., Zhu X., Chen Y., Chang Y. Application of embryonic and adult zebrafish for nanotoxicity assessment. Methods Mol. Biol. (Clifton, NJ) 2012, 926:317-329.
48. Rizzo L.Y., Golombek S.K., Mertens M.E., Pan Y., Laaf D., Broda J., et al. In vivo nanotoxicity testing using the zebrafish embryo assay. J. Mater. Chem. B 2013, 1:3918-3925.
49. Childs S., Chen J.-N., Garrity D.M., Fishman M.C. Patterning of angiogenesis in the zebrafish embryo. Development 2002, 129:973-982.
50. Cheng J., Chan C.M., Veca L.M., Poon W.L., Chan P.K., Qu L., et al. Acute and long-term effects after single loading of functionalized multi-walled carbon nanotubes into zebrafish (Danio rerio). Toxicol. Appl. Pharmacol. 2009, 235:216-225.
51. Cheng J., Flahau E., Cheng S.H. Effect of carbon nanotubes on developing zebrafish (Danio rerio) embryos. Environ. Toxicol. Chem. 2007, 26:708-716.
52. 2 exposure in zebrafish (Danio rerio) embryos. Nanotoxicology 2013, 7:1315-1324.
53. Zhu X., Zhu L., Duan Z., Qi R., Li Y., Lang Y. Comparative toxicity of several metal oxide nanoparticle aqueous suspensions to Zebrafish (Danio rerio) early developmental stage. J. Environ. Sci. Health Part A Toxic/Hazard. Subst. Environ. Eng. 2008, 43:278-284.
54. Zhu X., Tian S., Cai Z. Toxicity assessment of iron oxide nanoparticles in zebrafish (Danio rerio) early life stages. PLoS ONE 2012, 7:e46286.
55. 2 nanoparticles on oxidative stress and histopathological changes in juvenile carp (Cyprinus carpio). J. Environ. Sci. 2009, 21:1459-1466.
56. 2 nanoparticles to study the effect of particle size on zebrafish embryo toxicity. Analyst Mar 7 2014, 139(5):964-972.
57. Duan J., Yu Y., Li Y., Yu Y., Sun Z. Cardiovascular toxicity evaluation of silica nanoparticles in endothelial cells and zebrafish model. Biomaterials 2013, 34:5853-5862.
58. Wang Kan, Ma Jiebing, He Meng, Gao Guo, Xu Hao, Sang Jie, et al. Toxicity assessments of near-infrared upconversion luminescent LaF3:Yb,Er in early development of zebrafish embryos. Theranostics 2013, 3:258-266.
59. Goishi K., Klagsbrun M. Vascular endothelial growth factor and its receptors in embryonic zebrafish blood vessel development. Current Topics in Developmental Biology 2004, 127-152. Academic Press. P.S. Gerald (Ed.).
60. Bayne C.J., Gerwick L. The acute phase response and innate immunity of fish. Dev. Comp. Immunol. 2001, 25:725-743.
61. Lee K.C., Goh W.L., Xu M., Kua N., Lunny D., Wong J.S., et al. Detection of the p53 response in zebrafish embryos using new monoclonal antibodies. Oncogene 2008, 27:629-640.
62. Barylko B., Jung G., Albanesi J.P. Structure, function, and regulation of myosin 1C. Acta biochim. Pol. 2005, 52:373-380.
63. Tiwari A., Jung J.J., Inamdar S.M., Nihalani D., Choudhury A. The myosin motor Myo1c is required for VEGFR2 delivery to the cell surface and for angiogenic signaling. Am. J. Physiol. Heart Circ. Physiol. 2013, 304:H687-H696.
64. Brandstaetter H., Kendrick-Jones J., Buss F. Molecular roles of Myo1c function in lipid raft exocytosis. Commun. Integr. Biol. 2012, 5:508-510.
65. Wagner M.C., Blazer-Yost B.L., Boyd-White J., Srirangam A., Pennington J., Bennett S. Expression of the unconventional myosin Myo1c alters sodium transport in M1 collecting duct cells. Am. J. Physiol. Cell Physiol. 2005, 289:C120-C129.
66. Vogel C., Marcotte E.M. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat. Rev. Genet. 2012, 13:227-232.